The chemical substance known as "6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-" with the CAS number 870615-40-0 is a complex organic compound characterized by its multi-ring structure, which includes a triazole and benzodiazepine moiety. This compound features various functional groups, including an acetamide and multiple aromatic rings, contributing to its potential biological activity. The presence of the indole and phenyl groups suggests possible interactions with biological targets, making it of interest in medicinal chemistry. The stereochemistry indicated by the (-) designation suggests that it exists as a specific enantiomer, which can significantly influence its pharmacological properties. Overall, this compound's intricate structure and functional diversity may provide avenues for research in drug development, particularly in areas related to neuropharmacology or other therapeutic applications. However, detailed studies would be necessary to elucidate its specific properties and potential uses.

6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetaMide, 4,5-dihydro-4-(1H-indol-3-ylMethyl)-N-(1-Methylethyl)-5-oxo-1-phenyl-N-(phenylMethyl)-, (-)-

870615-40-0: The chemical substance known as "6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-" with the CAS number 870615-40-0 is a complex organic compound characterized by its multi-ring structure, which includes a triazole and benzodiazepine moiety. This compound features various functional groups, including an acetamide and multiple aromatic rings, contributing to its potential biological activity. The presence of the indole and phenyl groups suggests possible interactions with biological targets, making it of interest in medicinal chemistry. The stereochemistry indicated by the (-) designation suggests that it exists as a specific enantiomer, which can significantly influence its pharmacological properties. Overall, this compound's intricate structure and functional diversity may provide avenues for research in drug development, particularly in areas related to neuropharmacology or other therapeutic applications. However, detailed studies would be necessary to elucidate its specific properties and potential uses.

CE-326597, a potent CCK1R agonist, plays a key role in nutrient balance and post-meal fullness, with potential for obesity treatment.

CAS 870615-40-0

6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetaMide, 4,5-dihydro-4-(1H-indol-3-ylMethyl)-N-(1-Methylethyl)-5-oxo-1-phenyl-N-(phenylMethyl)-, (-)-

CE-326597

Ref: TM-T68482